Calcium Regulation of NF-kB Activation in Lymphocytes
Calcium Regulation of NF-kB Activation in Lymphocytes
批准号:
9352513
负责人:
BRUCE D FREEDMAN
金额:
$57.6万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-23 至 2018-08-31
关键词:
AddressAffinityAntigen ReceptorsAntigensAvidityBiochemicalBiochemical GeneticsCD28 AntigensCD28 geneCD8B1 geneCalciumCalcium SignalingCalcium ionCellsCompetenceCustomDataDefectDevelopmentDiseaseExhibitsFrequenciesFutureGene ExpressionGenerationsGenesGenetic TranscriptionImageImmuneImmune responseImmunityIndividualLifeLigationLinkLymphocyteMass Spectrum AnalysisMeasurementMediatingModificationMolecularMusNF-kappa BNatureNuclearPatternPerfusionPhenotypePhosphorylationPhysiologic pulsePlayProteinsPublic HealthPublicationsRegulationReporterRoleSTIM1 geneSignal TransductionSpecificitySystemT-LymphocyteTNF geneTimeTranscriptional RegulationVariantWidthbasedesignin vivoinnovationinsightlive cell imagingnovelp65preventprogenitorprogramsreceptortherapeutic targetthymocytetooltranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Antigen receptor-induced calcium (Ca2+) signals regulate lymphocyte development and effector functions, but
major gaps persist in our understanding of the dynamics of these signals, their transcriptional consequences
and how cell fates are governed by distinct receptor-induced Ca2+ waveforms. Supporting data in this
application and a pending publication reveal entirely novel and indispensable mechanisms by which Ca2+
specifically tunes TCR, but not TNF, induced NF-κB p65 and c-Rel activation. Our findings that p65 and c-Rel
phosphorylation may serve as Ca2+ dependent checkpoints provide a framework for understanding how distinct
patterns of Ca2+ signaling in vivo control the transcriptional programs that drive lymphocyte development and
function. Central to TCR-induced Ca2+ entry are the ER transmembrane Ca2+ sensing STIM1 and STIM2
proteins, and the STIM-activated Ca2+ channel CRAC/Orai. Mice whose T cell progenitors lack STIM1/2 exhibit
a selective defect in nTreg induction and the immune phenotype of these mice is virtually indistinguishable
from that of mice with a c-Rel deficiency. Moreover, as nTreg development is driven by CD28 costimulation in
conjunction with high affinity/avidity TCR ligation, and we have previously shown that CD28 biases this
deterministic signal toward high amplitude Ca2+ spikes over a range of antigen receptor ligation avidities, we
hypothesize that CD28 tuning of TCR induced Ca2+ dynamics generates a quantitatively unique waveform that
drives c-Rel-dependent nTreg generation. Based on our pending publication and new supporting data, we
hypothesize that TCR induced Ca2+-dependent phosphorylation of individual p65 and c-Rel Ser/Thr residues is
regulated by distinct Ca2+ thresholds and waveforms, thereby providing a mechanism by which quantitatively
distinct Ca2+ signals differentially regulate NF-κB-dependent gene expression controlling lymphocyte
development and functions. To address this hypothesis, we will: 1) Define the nature and function of Ca2+-
regulated phosphorylation of p65 and c-Rel, 2) determine how Ca2+ controls NF-κB-driven transcriptional
specificity, and 3) define the Ca2+ dependent mechanisms of thymic nTreg development. We will use a custom
built “Ca2+ clamp” perfusion system to impose variations in the Ca2+ amplitude, pulse width, frequency, and
total input to define how Ca2+ waveforms control sequential checkpoints in NF-B activation and long-term
imaging measurements utilizing a novel genetically encoded Ca2+ indicator (GCaMP6f) to determine how
antigen-induced Ca2+ signals contribute to the regulation of nTreg development. The combined expertise of the
team, the systems and approaches, and the quantitative tools developed for these studies will provide a new
and detailed mechanistic understanding of how calcium dependent phosphorylation regulates transcriptional
specificity of NF-B in T cells and will provide insights into strategies and therapeutic targets for enhancing
insufficient, suppressing auto-reactive, or redirecting inappropriate immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oncolytic virus targeting Schistosomes
-
批准号:10372084
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Building Enhanced Capability for the PennVet Multiphoton Core
-
批准号:9075603
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:BRUCE D FREEDMAN
-
依托单位:
FLIM system, resonant scanner, and UV laser for 2 photon microscope
-
批准号:7794472
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2010
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel mechanisms of Ca2+ signaling in B lymphocytes
-
批准号:6923251
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel Mechanisms of Calcium Signaling in B lymphocytes
-
批准号:8605495
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel mechanisms of Ca2+ signaling in B lymphocytes
-
批准号:7339631
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel Mechanisms of Calcium Signaling in B lymphocytes
-
批准号:8211059
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel Mechanisms of Calcium Signaling in B lymphocytes
-
批准号:7887578
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel mechanisms of Ca2+ signaling in B lymphocytes
-
批准号:7172920
-
项目类别:
-
资助金额:$37.57万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel Mechanisms of Calcium Signaling in B lymphocytes
-
批准号:8417768
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel Mechanisms of Calcium Signaling in B lymphocytes
-
批准号:8012265
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel mechanisms of Ca2+ signaling in B lymphocytes
-
批准号:7552021
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
Novel mechanisms of Ca2+ signaling in B lymphocytes
-
批准号:7008181
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2005
-
负责人:BRUCE D FREEDMAN
-
依托单位:
HIV ENV & MACROPHAGE CHEMOKINE RECEPTOR IONIC SIGNALING
-
批准号:6748995
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:BRUCE D FREEDMAN
-
依托单位:
HIV ENV & MACROPHAGE CHEMOKINE RECEPTOR IONIC SIGNALING
-
批准号:6511435
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:BRUCE D FREEDMAN
-
依托单位:
HIV ENV & MACROPHAGE CHEMOKINE RECEPTOR IONIC SIGNALING
-
批准号:6312479
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:BRUCE D FREEDMAN
-
依托单位:
HIV ENV & MACROPHAGE CHEMOKINE RECEPTOR IONIC SIGNALING
-
批准号:6632384
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2001
-
负责人:BRUCE D FREEDMAN
-
依托单位:
IONIC CONDUCTANCES AND CD4 LYMPHOCYTE DIFFERENTIATION
-
批准号:6373525
-
项目类别:
-
资助金额:$22.04万
-
财政年份:1997
-
负责人:BRUCE D FREEDMAN
-
依托单位:
IONIC CONDUCTANCES AND CD4 LYMPHOCYTE DIFFERENTIATION
-
批准号:6169741
-
项目类别:
-
资助金额:$21.4万
-
财政年份:1997
-
负责人:BRUCE D FREEDMAN
-
依托单位:
IONIC CONDUCTANCES AND CD4 LYMPHOCYTE DIFFERENTIATION
-
批准号:2672750
-
项目类别:
-
资助金额:$20.23万
-
财政年份:1997
-
负责人:BRUCE D FREEDMAN
-
依托单位:
海外基金